Circulating endothelial-coagulative activation markers after smoking cessation: A 12-month observational study

European Journal of Clinical Investigation

Volumn 41, Issue 6, 2011, Pages 616-626

  Caponnetto, Pasquale ^a   Russo, Cristina ^a   Di Maria, Annalisa ^a   Morjaria, Jaymin B ^b   Barton, Sheila ^b   Guarino, Francesca ^a   Basile, Elisa ^c   Proiti, Maria ^c   Bertino, Gaetano ^c   Cacciola, Rossella R ^a   Polosa, Riccardo ^a,c  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c S Marta Hospital   (Italy)

Author keywords

Clotting activation; Endothelial function; Platelet activation; Smoking cessation

Indexed keywords

BETA THROMBOGLOBULIN; BIOLOGICAL MARKER; D DIMER; PROTHROMBIN; THROMBOCYTE FACTOR 4; THROMBOMODULIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; DEMOGRAPHY; DISEASE PREDISPOSITION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SMOKING CESSATION; STATISTICAL SIGNIFICANCE; THROMBOCYTE ACTIVATION; THROMBOSIS;

ADULT; BIOLOGICAL MARKERS; BLOOD COAGULATION; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK; SMOKING; SMOKING CESSATION; TIME FACTORS;

EID: 79955623053     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02449.x     Document Type: Article

References (60)

1. Bartecchi CE, MacKenzie TD, Schrier RW. The human costs of tobacco use (1). N Engl J Med 1994;330:907-12.
2. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40years' observations on male British doctors. BMJ 1994;309:901-11.
3. Landmark K, Abdelnoor M. Current smokers develop more posterior myocardial infarctions probably due to increased tendency to thrombosis. Scand Cardiovasc J 2000;34:73-8.
4. Pittilo R. Cigarette smoking, endothelial injury and cardiovascular disease. Int J Exp Pathol 2000;81:219-30.
5. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993;88:2149-55.
6. Cacciola RR, Guarino F, Polosa R. Relevance of endothelial-haemostatic dysfunction in cigarette smoking. Curr Med Chem 2007;14:1887-92.
7. Haller H. Risk factors for cardiovascular disease and the endothelium. In: Bonn G, Schatiaur C, editors. Vascular Endothelium: Physiology, Pathology and Therapeutic Opportunities. Stuggart: New Horizon Series 3, Schattauer; 1997:273-86.
8. Pittilo RM. Endothelium and the vessel wall. In: Pittilo R, Maohin SJ, editors. Smoking and Platelet-Vessel Wall Interactions. The Bloomsbury Series in Clinical Science. Vol. 70. London: Springer-Verlag; 1988:707-11.
9. Blann AD, McCollum CN. Adverse influence of cigarette smoking on the endothelium. Thromb Haemost 1993;70:707-11.
10. Tithof PK, Elgayyar M, Schuller HM, Barnhill M, Andrews R. 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a nicotine derivative, induces apoptosis of endothelial cells. Am J Physiol Heart Circ Physiol 2001;281:H1946-54.
11. Blann AD, Kirkpatrick U, Devine C, Naser S, McCollum CN. The influence of acute smoking on leucocytes, platelets and the endothelium. Atherosclerosis 1998;141:133-9.
12. Lee SD, Lee DS, Chun YG, Shim TS, Lim CM, Koh Y et al. Cigarette smoke extract induces endothelin-1 via protein kinase C in pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 2001;281:L403-11.
13. Blann AD, Taberner DA. A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol 1995;90:244-8.
14. Markuljak I, Ivankova J, Kubisz P. Thrombomodulin and von Willebrand factor in smokers and during smoking. Nouv Rev Fr Hematol 1995;37:137-9.
15. Ware JA, Heistad DD. Seminars in medicine of the Beth Israel Hospital, Boston. Platelet-endothelium interactions. N Engl J Med 1993;328:628-35.
16. Takano S, Kimura S, Ohdama S, Aoki N. Plasma thrombomodulin in health and diseases. Blood 1990;76:2024-9.
17. Dahlback B. Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism. J Clin Invest 1994;94:923-7.
18. Marcus AJ, Weksler BB, Jaffe EA, Broekman MJ. Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells. J Clin Invest 1980;66:979-86.
19. Kaplan KL, Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981;57:199-202.
20. Rangemark C, Benthin G, Granstrom EF, Persson L, Winell S, Wennmalm A. Tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in women stratified by age. Circulation 1992;86:1495-500.
21. Nowak J, Murray JJ, Oates JA, FitzGerald GA. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation 1987;76:6-14.
22. Blann AD, Lanza F, Galajda P, Gurney D, Moog S, Cazenave JP et al. Increased platelet glycoprotein V levels in patients with coronary and peripheral atherosclerosis--the influence of aspirin and cigarette smoking. Thromb Haemost 2001;86:777-83.
23. Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med 2007;4:e297.
24. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 2007;4:e296.
25. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
26. Smoking Cessation. In: U.S. Department of Health and Human Services PHS, Agnecy for Health Care Policy and Research, editor. Rockville, MD: Government Printing Office; 1996.
27. Piccillo G, Caponnetto P, Barton S, Russo C, Origlio A, Bonaccorsi A et al. Changes in airway hyperresponsiveness following smoking cessation: comparisons between Mch and AMP. Respir Med 2008;102:256-65.
28. Fagerstrom KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med 1989;12:159-82.
29. Casella G, Caponnetto P, Polosa R. Therapeutic advances in the treatment of nicotine addiction: present and future. Ther Adv Chronic Dis 2010;1:95-106.
30. Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 2005;26:1765-73.
31. Negri E, La Vecchia C, D'Avanzo B, Nobili A, La Malfa RG. Acute myocardial infarction: association with time since stopping smoking in Italy. GISSI-EFRIM Investigators. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto. Epidemiologia dei Fattori di Rischio dell'Infarto Miocardico. J Epidemiol Community Health 1994;48:129-33.
32. Barua RS, Ambrose JA, Eales-Reynolds LJ, DeVoe MC, Zervas JG, Saha DC. Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation. Circulation 2001;104:1905-10.
33. Michaud SE, Dussault S, Groleau J, Haddad P, Rivard A. Cigarette smoke exposure impairs VEGF-induced endothelial cell migration: role of NO and reactive oxygen species. J Mol Cell Cardiol 2006;41:275-84.
34. Mazzone A, Cusa C, Mazzucchelli I, Vezzoli M, Ottini E, Ghio S et al. Cigarette smoking and hypertension influence nitric oxide release and plasma levels of adhesion molecules. Clin Chem Lab Med 2001;39:822-6.
35. Heitzer T, Brockhoff C, Mayer B, Warnholtz A, Mollnau H, Henne S et al. Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: evidence for a dysfunctional nitric oxide synthase. Circ Res 2000;86:E36-41.
36. Fang Q, Sun H, Mayhan WG. Impairment of nitric oxide synthase-dependent dilatation of cerebral arterioles during infusion of nicotine. Am J Physiol Heart Circ Physiol 2003;284:H528-34.
37. Balakumar P, Sharma R, Singh M. Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat. Pharmacol Res 2008;58:356-63.
38. Blann AD, Steele C, McCollum CN. The influence of smoking on soluble adhesion molecules and endothelial cell markers. Thromb Res 1997;85:433-8.
39. Hjerkinn EM, Seljeflot I, Sandvik L, Hjermann I, Arnesen H. Markers of endothelial cell activation in elderly men at high risk for coronary heart disease. Scand J Clin Lab Invest 2005;65:201-9.
40. Blann AD, McCollum CN, Lip GY. Relationship between plasma markers of endothelial cell integrity and the Framingham cardiovascular disease risk-factor scores in apparently healthy individuals. Blood Coagul Fibrinolysis 2002;13:513-8.
41. Fusegawa Y, Goto S, Handa S, Kawada T, Ando Y. Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers. Thromb Res 1999;93:271-8.
42. Ruggeri ZM. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost 2003;1:1335-42.
43. Lee AJ, Fowkes FG, Lowe GD, Rumley A. Fibrin d-dimer, haemostatic factors and peripheral arterial disease. Thromb Haemost 1995;74:828-32.
44. Yarnell JW, Sweetnam PM, Rumley A, Lowe GD. Lifestyle factors and coagulation activation markers: the Caerphilly Study. Blood Coagul Fibrinolysis 2001;12:721-8.
45. Hioki H, Aoki N, Kawano K, Homori M, Hasumura Y, Yasumura T et al. Acute effects of cigarette smoking on platelet-dependent thrombin generation. Eur Heart J 2001;22:56-61.
46. Hung J, Lam JY, Lacoste L, Letchacovski G. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation 1995;92:2432-6.
47. Rendu F, Brohard-Bohn B. The platelet release reaction: granules' constituents, secretion and functions. Platelets 2001;12:261-73.
48. De Meyer GR, Herman AG. Vascular endothelial dysfunction. Prog Cardiovasc Dis 1997;39:325-42.
49. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000;101:1899-906.
50. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001;104:2673-8.
51. Critchley J, Capewell S. Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev 2004;1:CD003041.
52. Dagenais GR, Yi Q, Lonn E, Sleight P, Ostergren J, Yusuf S. Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial. Eur J Cardiovasc Prev Rehabil 2005;12:75-81.
53. Woodward M, Lam TH, Barzi F, Patel A, Gu D, Rodgers A et al. Smoking, quitting, and the risk of cardiovascular disease among women and men in the Asia-Pacific region. Int J Epidemiol 2005;34:1036-45.
54. Oren S, Isakov I, Golzman B, Kogan J, Turkot S, Peled R et al. The influence of smoking cessation on hemodynamics and arterial compliance. Angiology 2006;57:564-8.
55. Hatsukami DK, Kotlyar M, Allen S, Jensen J, Li S, Le C et al. Effects of cigarette reduction on cardiovascular risk factors and subjective measures. Chest 2005;128:2528-37.
56. Haustein KO, Krause J, Haustein H, Rasmussen T, Cort N. Changes in hemorheological and biochemical parameters following short-term and long-term smoking cessation induced by nicotine replacement therapy (NRT). Int J Clin Pharmacol Ther 2004;42:83-92.
57. Hosokawa S, Hiasa Y, Miyazaki S, Ogura R, Miyajima H, Ohara Y et al. Effects of smoking cessation on coronary endothelial function in patients with recent myocardial infarction. Int J Cardiol 2008;128:48-52.
58. Whincup PH, Danesh J, Walker M, Lennon L, Thomson A, Appleby P et al. von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J 2002;23:1764-70.
59. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995;332:635-41.
60. Bize R, Burnand B, Mueller Y, Rege Walther M, Cornuz J. Biomedical risk assessment as an aid for smoking cessation. Cochrane Database Syst Rev 2009;2:CD004705.